AEON Biopharma AEON
NYSE AEON
$0.18 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

AEON Biopharma (AEON) EBITDA (2022 - 2026)

Updated

AEON Biopharma's EBITDA was -$5.49 million in Q4 2025, compared with -$2.3 million a year earlier.

Analysis

AEON Biopharma (AEON) EBITDA (2022 - 2026) Analysis & Trends

For FY2025, EBITDA at AEON Biopharma came in at -$12.73 million.

  • In earlier years, EBITDA was $73.08 million in FY2024, -$318.4 million in FY2023 and -$48.36 million in FY2022.
  • The Q4 2025 figure marks the lowest quarterly EBITDA since Q1 2024.
  • Per Business Quant data, AEON's EBITDA in the three quarters before Q4 2025 was -$2.47 million (Q3 2025), -$4.32 million (Q2 2025) and -$443,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 13.33 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 8.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 8.16 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 7.37 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 4.20 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 7.05 Bn
10 AEON Biopharma 9.26 Mn -9.35 Mn - -5.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.90 Mn
Mar 31, 2026 -5.91 Mn
Dec 31, 2025 -5.49 Mn
Sep 30, 2025 -2.47 Mn
Jun 30, 2025 -4.32 Mn
Mar 31, 2025 -443,000.00
Dec 31, 2024 -2.30 Mn
Jun 30, 2024 153.50 Mn
Mar 31, 2024 -74.13 Mn
Sep 30, 2023 -283.69 Mn
Mar 31, 2023 -13.02 Mn
Dec 31, 2022 -15.00 Mn
API Access

AEON Biopharma EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=AEON&period=max&api_key=YOUR_API_KEY